New
Pharmaceuticals research report from GlobalData is now available
from Fast Market Research
Nov 26, 2010
– Global Market Direct's pharmaceuticals report, "Urigen
Pharmaceuticals - Product Pipeline Review - Q4 2010" provides
data on the company's research and development focus. The
report includes information on current developmental pipeline,
complete with latest updates, and features on discontinued and
dormant projects. It also gives a complete picture of the
company's future therapy areas of focus.
This report is built using data and information sourced from
Global Markets Direct's proprietary databases, primary and
secondary research using Company's corporate website, SEC
filings, investor presentations and featured press releases,
both from company and industry-specific third party sources,
put together with in-house analysis, by Global Markets
Direct's team of industry experts.
Scope
* Urigen Pharmaceuticals - company overview including business
description, key employees, and other facts.
* Review of current pipeline of Urigen Pharmaceuticals human
therapeutic division.
* Overview of pipeline therapeutics across various therapy
areas.
* Coverage of current pipeline molecules in various stages of
drug development, including the combination treatment
modalities, for the pharmaceutical markets across the globe.
* Product profiles for late stage and clinical stage products
of Urigen Pharmaceuticals with complete description of the
product's developmental history, mechanism of action, clinical
trials, major milestones and others.
* Recent updates of the Urigen Pharmaceuticals's pipeline in
the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.
Reasons to buy
* Evaluate Urigen Pharmaceuticals's strategic position with
total access to a detailed intelligence on its product
pipeline.
* Assess the growth potential of Urigen Pharmaceuticals in its
therapy areas of focus.
* Identify new drug targets and therapeutic classes in the
Urigen Pharmaceuticals's R&D portfolio and develop key
strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of
opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with
Urigen Pharmaceuticals.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Urigen
Pharmaceuticals and identify potential opportunities in those
areas.
* Do deals with an understanding of the mergers and
partnerships that have shaped the sector.
About GlobalData
GlobalData is a leading provider of global business
intelligence including market, competitor, product and
customer information. It provides in-depth research, analysis,
data and forecasts through a range of interactive online
databases, reports and management briefings. GlobalData has a
large team of experienced research and analysis, consulting,
and marketing experts. It has a global presence, including key
offices in the US, Europe and Asia. The group has over 50
years of experience of delivering market intelligence data and
analysis and a highly experienced senior management team.
About Fast Market Research
Fast Market Research is an online aggregator and distributor
of market research and business information. We represent the
world's top research publishers and analysts and provide quick
and easy access to the best competitive intelligence
available.
For more information about these or
related research reports
Fast Market Research is an online aggregator and distributor
of market research and business information. We represent the
world's top research publishers and analysts and provide quick
and easy access to the best competitive intelligence
available.
Quality
